Financial Fraud Law

Recent Posts

Whistleblower Nets $1.1 Million in False Claims Act Case against Bristol-Myers Squibb
Posted on 18 Mar 2014 by Steven A. Meyerowitz

New York has reached a $6.2 million settlement of a whistleblower case alleging that a medical imaging company that made millions of dollars’ worth of sales in New York knowingly evaded New York State and New York City taxes. The whistleblower... Read More

Omnicare Reaches $4.19 Million Settlement of Whistleblower Suit Alleging Kickbacks
Posted on 28 Feb 2014 by Steven A. Meyerowitz

Omnicare Inc., an Ohio-based long term care pharmacy, has agreed to pay the U.S. government $4.19 million to settle allegations that it engaged in a kickback scheme in violation of the federal False Claims Act. Omnicare provides pharmaceuticals and services... Read More

US Government Sues Kellogg, Brown & Root Services, Alleging Kickbacks and False Claims Relating to Iraq Support Services Contract
Posted on 27 Jan 2014 by Steven A. Meyerowitz

The U.S. government has filed a complaint against Kellogg, Brown & Root Services Inc. (KBR) and Kuwaiti companies La Nouvelle General Trading & Contracting Co. and First Kuwaiti Trading Co. for allegedly submitting false claims in connection with... Read More

Whistleblower to Receive $63.9 Million in JPMorgan Mortgage Loan Case
Posted on 10 Mar 2014 by Steven A. Meyerowitz

As readers of the Financial Fraud Law Report and the Financial Fraud Law Blog certainly recall, JPMorgan Chase settled a couple of big, big Madoff-related cases some weeks ago, reaching a $2.05 billion settlement with federal prosecutors over its failure... Read More

$300 Million Tax Fraud Suit Against Sprint-Nextel May Proceed, Appeals Court Rules
Posted on 28 Feb 2014 by Steven A. Meyerowitz

A first-of-its-kind lawsuit against Sprint-Nextel Corporation, alleging that it deliberately undercollected and underpaid millions of dollars in New York State and local sales taxes on flat-rate access charges for wireless calling plans, may continue... Read More

Lidoderm Settlement Costs Endo Pharmaceuticals $192.7 Million
Posted on 21 Feb 2014 by Steven A. Meyerowitz

Pharmaceutical company Endo Health Solutions Inc. and its subsidiary Endo Pharmaceuticals Inc. have agreed to pay $192.7 million to resolve criminal and civil liability arising from Endo’s marketing of the prescription drug Lidoderm for uses not... Read More